fluoxetine has been researched along with 1-(3-chlorophenyl)piperazine in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.16) | 18.7374 |
| 1990's | 15 (39.47) | 18.2507 |
| 2000's | 13 (34.21) | 29.6817 |
| 2010's | 5 (13.16) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
| Baumann, MH; Hufeisen, SJ; McBride, A; Rauser, L; Roth, BL; Rothman, RB; Savage, JE | 1 |
| Buck, LB; Petrascheck, M; Ye, X | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Janowsky, DS; Overstreet, DH; Rezvani, AH | 1 |
| DeCaria, C; Gorman, JM; Gully, R; Hollander, E; Klein, DF; Liebowitz, MR; Nitescu, A; Suckow, RF | 1 |
| Bihari, K; Hill, JL; Murphy, DL; Pato, MT | 1 |
| Frances, H; Khidichian, F | 1 |
| Cooper, SJ; Neill, JC | 1 |
| Bero, LA; Kuhn, CM | 1 |
| Campeas, R; DeCaria, C; Hollander, E; Liebowitz, MR; Papp, L | 1 |
| Cerrito, F; Preziosi, P; Vacca, M | 1 |
| Pettibone, DJ; Williams, M | 1 |
| Blackburn, TP; de Biasi, V; Kennett, GA; Lightowler, S; Stevens, NC; Tulloch, IF; Wood, MD | 1 |
| Bertrand, J; Costentin, J; Simon, P | 1 |
| Auerbach, SB; Baumann, MH; Rutter, JJ | 1 |
| DeCaria, CM; Hollander, E; Klein, DF; Liebowitz, MR; Saoud, JB; Stein, DJ | 1 |
| Maj, J; Moryl, E | 1 |
| Aulakh, CS; Hill, JL; Lesch, KP; Murphy, DL; Tolliver, TJ; Wolozin, BL | 1 |
| Gale, K; Pasini, A; Tortorella, A | 1 |
| Schechter, MD | 1 |
| Danaceau, MA; Murphy, DL; Rosenstein, DL; Rubinow, DR; Schmidt, PJ; Su, TP; Tobin, MB | 1 |
| Demedts, P; Maes, M; Meltzer, HY; Neels, H; Vandoolaeghe, E; Wauters, A; Westenberg, H | 1 |
| Bristow, LJ; Duxon, MS; Hutson, PH; O'Connor, D; Watts, R | 1 |
| Cryan, JF; Lucki, I | 1 |
| Anheuer, ZE; Bagdy, G; Graf, M; Kantor, S; Modos, EA | 1 |
| Bagdy, G; Gerber, K; Graf, M; Halasz, P; Jakus, R; Juhasz, G; Levay, G | 1 |
| Biba, A; Christodoulou, A; Chrysikakou, S; Giannou, H; Kontis, D; Maillis, A; Pallidi, S; Rabavilas, A; Tsaltas, E | 1 |
| Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
| Barsvári, B; Haller, J; Levay, G; Leveleki, C; Mikics, E; Soproni, K; Sziray, N | 1 |
| Harvey, BH; Korff, S; Stein, DJ | 1 |
| Boulougouris, V; Kalogerakou, S; Kontis, D; Papadimitriou, GN; Papadopoulos, S; Papakosta, VM; Poulopoulou, C; Tsaltas, E | 1 |
| Amitani, H; Asakawa, A; Fujimiya, M; Fujitsuka, N; Hayashi, M; Inui, A; Kojima, S; Sameshima, M | 1 |
| Arai, Y; Chancellor, MB; de Groat, WC; Kaiho, Y; Kamo, I; Kitta, T; Miyazato, M; Sugaya, K; Yoshimura, N | 1 |
| Adori, C; Andó, RD; Bagdy, G; Ferrington, L; Kelly, PA; Kirilly, E; Kovács, GG; Molnár, E | 1 |
| Faingold, CL; Mhaskar, Y; Randall, M; Uteshev, VV | 1 |
| Arrant, AE; Coburn, E; Jacobsen, J; Kuhn, CM | 1 |
| Arai, Y; Kaiho, Y; Kawamorita, N; Miyazato, M; Yoshimura, N | 1 |
5 trial(s) available for fluoxetine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
Topics: Adult; Arousal; Brain; Female; Fluoxetine; Humans; Hydrocortisone; Male; Obsessive-Compulsive Disorder; Piperazines; Psychiatric Status Rating Scales; Receptors, Serotonin | 1991 |
More on self mutilation and obsessive compulsive disorder.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Random Allocation; Self Mutilation | 1988 |
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Ambulatory Care; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prognosis; Prolactin; Serotonin Antagonists | 1993 |
Fluoxetine in the treatment of premenstrual dysphoria.
Topics: Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Fluoxetine; Humans; Middle Aged; Personality Inventory; Piperazines; Premenstrual Syndrome; Prospective Studies; Self-Assessment; Serotonin Receptor Agonists | 1997 |
Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Piperazines; Trazodone; Treatment Outcome | 1997 |
33 other study(ies) available for fluoxetine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergonovine; Norfenfluramine; Receptors, Serotonin; Serotonin Antagonists | 2000 |
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Drinking Behavior; Ethanol; Feeding Behavior; Fluoxetine; Male; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Rats, Wistar; Scopolamine; Self Administration; Serotonin Receptor Agonists; Species Specificity; Verapamil | 1991 |
Neurologic soft signs in obsessive-compulsive disorder.
Topics: Adult; Anxiety Disorders; Central Nervous System Diseases; Clomipramine; Clonidine; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Piperazines | 1991 |
Chronic but not acute antidepressants interfere with serotonin (5-HT1B) receptors.
Topics: Animals; Antidepressive Agents; Escape Reaction; Fluoxetine; Indoles; Injections, Intraperitoneal; Male; Mice; Phenelzine; Piperazines; Receptors, Serotonin; Time Factors | 1990 |
Selective reduction by serotonergic agents of hypertonic saline consumption in rats: evidence for possible 5-HT1C receptor mediation.
Topics: Animals; Dose-Response Relationship, Drug; Drinking Behavior; Fenfluramine; Fluoxetine; Hypertonic Solutions; Indoles; Male; Piperazines; Pyrazines; Quinoxalines; Quipazine; Rats; Receptors, Serotonin; Serotonin | 1989 |
Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Topics: 5-Hydroxytryptophan; Aging; Animals; Animals, Newborn; Corticosterone; Cyproheptadine; Fluoxetine; Growth Hormone; Morphine; p-Chloroamphetamine; Piperazines; Prolactin; Propylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin | 1987 |
Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, mCPP.
Topics: 5-Hydroxytryptophan; Animals; Corticosterone; Fluoxetine; Male; Naloxone; Piperazines; Prolactin; Rats; Rats, Inbred Strains | 1983 |
Serotonin-releasing effects of substituted piperazines in vitro.
Topics: Animals; Fluoxetine; Hypothalamus; In Vitro Techniques; Male; p-Chloroamphetamine; Piperazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1984 |
Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
Topics: Animals; Brain; Clomipramine; Desipramine; Fluoxetine; Male; Motor Activity; Norepinephrine; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors | 1994 |
5-HT1A receptor blockade increases penile erections induced by indirect serotonin agonists.
Topics: Adrenergic beta-Antagonists; Animals; Drug Synergism; Fenfluramine; Fluoxetine; Labetalol; Male; Penile Erection; Piperazines; Propanolamines; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 1993 |
Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
Topics: Animals; Diencephalon; Fluoxetine; Injections, Intravenous; Kinetics; Male; Microdialysis; Piperazines; Prolactin; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists; Time Factors | 1993 |
Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Body Temperature; Exploratory Behavior; Fenfluramine; Fluoxetine; Male; Mice; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Receptor Agonists | 1993 |
Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants.
Topics: Animals; Base Sequence; Brain Chemistry; Carrier Proteins; Clorgyline; Fluoxetine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Piperazines; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anticonvulsants; Bicuculline; Convulsants; Fenclonine; Fluoxetine; gamma-Aminobutyric Acid; Male; Microinjections; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Substantia Nigra | 1996 |
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Ibogaine; Male; Methoxydimethyltryptamines; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 1997 |
Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
Topics: Animals; Behavior, Animal; Fluoxetine; Indoles; Male; Motor Activity; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Urea | 2000 |
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Ethylamines; Fluoxetine; Indoles; Male; Mianserin; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Receptor Agonists; Swimming | 2000 |
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Topics: Aminopyridines; Animals; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Fluoxetine; Grooming; Indoles; Interpersonal Relations; Male; Motor Activity; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Sertraline | 2001 |
5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
Topics: Action Potentials; Aminopyridines; Animals; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Epilepsy, Absence; Fluoxetine; Indoles; Injections, Intraperitoneal; Injections, Intraventricular; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Desipramine; Diazepam; Disease Models, Animal; Fluoxetine; Indoles; Male; Maze Learning; Obsessive-Compulsive Disorder; Piperazines; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2C; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tryptamines | 2005 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Haloperidol; Male; Models, Neurological; Motor Activity; Phobic Disorders; Piperazines; Rats; Rats, Wistar; Reproducibility of Results; Serotonin Receptor Agonists; Stress, Psychological | 2006 |
Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Desipramine; Disease Models, Animal; Dopamine Agonists; Drug Evaluation, Preclinical; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Peromyscus; Piperazines; Quinpirole; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Species Specificity; Stereotyped Behavior | 2008 |
Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
Topics: Animals; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Fluoxetine; Male; Maze Learning; Obsessive-Compulsive Disorder; Piperazines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Time Factors | 2008 |
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
Topics: Animals; Drugs, Chinese Herbal; Eating; Fenfluramine; Fluoxetine; Fluvoxamine; Gastrointestinal Motility; Ghrelin; Growth Hormone; Injections, Intraventricular; Male; Oligopeptides; Paroxetine; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Ghrelin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2009 |
Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Female; Fluoxetine; Piperazines; Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sneezing; Spiro Compounds; Sulfonamides; Urethra; Urinary Incontinence, Stress | 2009 |
Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.
Topics: Animals; Anxiety; Axons; Brain; Citalopram; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuropsychological Tests; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Time Factors | 2010 |
Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice.
Topics: Animals; Brain Stem; Death, Sudden; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperazines; Receptors, Serotonin; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Species Specificity | 2011 |
Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Age Factors; Amygdala; Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Fluoxetine; Male; Piperazines; Prefrontal Cortex; Rats; Serotonin; Serotonin Receptor Agonists | 2013 |
Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.
Topics: Animals; Excitatory Amino Acid Antagonists; Female; Fluoxetine; Norepinephrine; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, AMPA; Reflex; Serotonin Receptor Agonists; Sneezing; Urethra; Urinary Incontinence, Stress | 2015 |